Proteome Sciences plc ('the Company')
Mr C Pearce, a director, has converted warrants into 642,840 ordinary shares at
US$0.75 per share on 31 March 2005. Following this transaction Mr Pearce now
holds 5,654,951 ordinary shares in the Company, representing 4.31 % of its
issued ordinary share capital as enlarged by the recent share issue.
Application will be made for the shares to be admitted to the Alternative
Investment Market ('AIM') of the London Stock Exchange plc.
Director Shareholding
Earlier from Proteome Sciences
- Stroke Biomarkers
- Result of Equity Issue
- Appointment of Adviser
- Statement re EU Grant Awarded
- Regulatory Approval
Later from Proteome Sciences
- Correction: Final Results
- Statement re Grant of Options
- Statement re License Update
- Correction: Statement re Lincense Update
- Correction: Doc re Interim Report
Follow Proteome Sciences into a list and get an email when it puts out news.
Follow Proteome Sciences